🇺🇸 FDA
Pipeline program

sodium zirconium cyclic silicate

2022CR08

Approved small_molecule active

Quick answer

sodium zirconium cyclic silicate for Potassium Imbalance is a Approved program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Potassium Imbalance
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials